Forced Vital Capacity Is a Strong Predictor for Postoperative Survival of Patients with Malignant Pleural Mesothelioma

被引：0
|
作者：
Yotsukura, M. [1 ]
Yoshida, Y. [1 ]
Nakagawa, K. [1 ]
Watanabe, S-i. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Malignant pleural mesothelioma; forced vital capacity; surgery;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP14.01-12
引用
收藏
页码：S717 / S717
页数：1
相关论文
共 50 条
  • [41] Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma
    Okubo K.
    Sonobe M.
    Fujinaga T.
    Shoji T.
    Sakai H.
    Miyahara R.
    Bando T.
    Date H.
    Shibuya K.
    Hiraoka M.
    General Thoracic and Cardiovascular Surgery, 2009, 57 (11) : 585 - 590
  • [42] Scleroderma lung: Initial forced vital capacity as predictor of pulmonary function decline
    Plastiras, Sotiris C.
    Karadimitrakis, Stylianos P.
    Ziakas, Panayiotis D.
    Vlachoyiannopoulos, Panayiotis G.
    Moutsopoulos, Haralampos M.
    Tzelepis, George E.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (04): : 598 - 602
  • [43] Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma
    Faccioli, Eleonora
    Terzi, Stefano
    Giraudo, Chiara
    Zuin, Andrea
    Modugno, Antonella
    Labella, Francesco
    Zambello, Giovanni
    Lorenzoni, Giulia
    Schiavon, Marco
    Gregori, Dario
    Pasello, Giulia
    Calabrese, Fiorella
    Dell'Amore, Andrea
    Rea, Federico
    CANCERS, 2022, 14 (15)
  • [44] Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma
    Thylén, A
    Hjerpe, A
    Martensson, G
    CANCER, 2001, 92 (05) : 1224 - 1230
  • [45] Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region
    Uramoto, Hidetaka
    Takiguchi, Tomoya
    Koizumi, Tomonobu
    Tanimoto, Azusa
    Hayashi, Ryuji
    Nakazawa, Yozo
    Ito, Ken-ichi
    Nakada, Mitsutoshi
    Hirono, Yasuo
    Nishino, Yoshikazu
    Yano, Seiji
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (05) : 1153 - 1158
  • [46] Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)
    Cedres, S.
    Romero, L.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Molina, G.
    Garcia-Illescas, D.
    Sanchez, L.
    Rosado, J.
    Carbonell, C.
    Frigola, J.
    Amat, R.
    Gonzalo, J.
    Navarro, V.
    Dienstmann, R.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S323 - S323
  • [47] The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
    Wang, Haoyu
    Yang, Ruiyuan
    Liu, Dan
    Li, Weimin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [48] Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses
    Paajanen, Juuso
    Laaksonen, Sanna
    Ilonen, Ilkka
    Vehmas, Tapio
    Mayranpaa, Mikko, I
    Sutinen, Eva
    Kettunen, Eeva
    Salo, Jarmo A.
    Rasanen, Jari
    Wolff, Henrik
    Myllarniemi, Marjukka
    CLINICAL LUNG CANCER, 2020, 21 (06) : E633 - E639
  • [49] Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma
    Otoshi, Takehiro
    Kataoka, Yuki
    Kaku, Sawako
    Iki, Reika
    Hirabayashi, Masataka
    IN VIVO, 2018, 32 (02): : 445 - 450
  • [50] Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
    Banks, Kian C.
    Ossowski, Stephanie
    Hung, Yun-Yi
    Hsu, Diana S.
    Ashiku, Simon K.
    Patel, Ashish R.
    Velotta, Jeffrey B.
    Suga, J. Marie
    CLINICAL LUNG CANCER, 2022, 23 (08) : 694 - 701
12345